01672.HK
Ascletis Pharma Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 10.09
−2.32%Margins
Gross margin
-221.1%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
-9991.7%
-37.5%
Return on equity
-34.7%
Return on assets
-50.7%
Return on invested capital
0.00x
Asset turnover
-HKD 383.7M
Cash from operations
HKD 2.72
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026